To install click the Add extension button. That's it.

The source code for the WIKI 2 extension is being checked by specialists of the Mozilla Foundation, Google, and Apple. You could also do it yourself at any point in time.

Kelly Slayton
Congratulations on this excellent venture… what a great idea!
Alexander Grigorievskiy
I use WIKI 2 every day and almost forgot how the original Wikipedia looks like.
What we do. Every page goes through several hundred of perfecting techniques; in live mode. Quite the same Wikipedia. Just better.

Cell surface receptor

From Wikipedia, the free encyclopedia

The seven-transmembrane α-helix structure of a G-protein-coupled receptor
The seven-transmembrane α-helix structure of a G-protein-coupled receptor

Cell surface receptors (membrane receptors, transmembrane receptors) are receptors that are embedded in the membranes of cells. They act in cell signaling by receiving (binding to) extracellular molecules. They are specialized integral membrane proteins that allow communication between the cell and the extracellular space. The extracellular molecules may be hormones, neurotransmitters, cytokines, growth factors, cell adhesion molecules, or nutrients; they react with the receptor to induce changes in the metabolism and activity of a cell. In the process of signal transduction, ligand binding affects a cascading chemical change through the cell membrane.

YouTube Encyclopedic

  • 1/5
    116 414
    240 961
    643 061
    3 228 867
    33 430
  • Membrane Receptors | Nervous system physiology | NCLEX-RN | Khan Academy
  • Overview of cell signaling
  • G Protein Coupled Receptors | Nervous system physiology | NCLEX-RN | Khan Academy
  • In Da Club - Membranes & Transport: Crash Course Biology #5
  • Neuromuscular Junction (NMJ) Structure and Action


Voiceover: In this video we're gonna talk a little bit about membrane receptors. Membrane receptors are really important because they are the things that actually allow ourselves to communicate with the outside world. Without membrane receptors our cells wouldn't be able to work together and they wouldn't be able to form the human body as we know it. And so a membrane receptor is essentially an integral protein that is embedded in the cell membrane that takes part in communication with the outside environment. And so for short I'm just gonna say it's an integral protein that communicates with the outside environment. And so the way membrane receptors work is that in our bodies there are a bunch of these signaling molecules going around. We call these extra cellular signaling molecules because they are outside our cells. Let's say this outside area is the extra cellular portion. Let's say we have a pink signaling molecule. And for the sake of diagramming I'm gonna say it looks like a triangle. Now in reality, of course, signaling molecules do not look like triangles. Signaling molecules can be a variety of things. They can be ions or molecules, essentially, that bind to another chemical entity. We also call these ligands. A ligand can be something like a neurotransmitter or a hormone or cell recognition molecules. And what these can do is these can attach to our membrane receptors and trigger changes inside the cell. I'm gonna do the membrane receptors in a nice blue color. And remember we say they're integral proteins. Integral proteins are proteins that go through the entire cell membrane. So let's say here we have our nice integral protein. And so what will happen, essentially, is this ligand will bind to our integral protein. And this integral protein, which, again, appears in our cell membrane will actually bind that nice triangle shaped ligand that we have. Like this. And so now what we have is our ligand receptor complex. It's just a fancy way of saying our ligand and our memory receptor have bound. And once this happens this can essentially tell the cell what to do. This can explain things like how hormones function, how our nerve impulses work, why our cells divide, cell death. It also explains why our cells allow certain things into the cell and other things not, sometimes. In terms of a bigger real world application, this is really critically important in designing pharmaceutical drugs. In fact, a very big percentage of pharmaceutical drugs actually target our membrane receptors. This is actually why some drugs can target specific cells. Like some drugs might only target your liver while other drugs might target your heart. And the reason why is because different cells might actually have different receptors. And these receptors might bind different things. This whole process of binding and telling the cell what to do, we actually have a really special name for it and that's called signal transduction. So this is a process that we call signal transduction. What happens during signal transduction is an extracellular signal molecule, so this is our ligand, binds to our membrane receptor, and these receptor proteins then cause an intracellular response. And so after binding there will be what's called an intracellular response. And so this receptor will bind to the protein and this will cause the protein to actually change confirmation which then activates intracellular signaling proteins. So proteins on the intracellular side of the cell. And this activates a cascade of protein signals that will alter the behavior of our cell. Sounds really complicated. Essentially the way this works is we have an original signal, our ligand. And this can be again a hormone, a neurotransmittor, something like that. And this original signal is passed along. And it'll bind to a protein and that protein will tell other proteins inside the cell about what's going on. And this signal is propagated throughout the cell causing the cell to perform a specific function. Now you'll notice that in the diagram we actually drew a really specific shape for our ligand. We chose a triangle. Now I chose a triangle because it's a little easier to draw, but this triangle actually fits right into the protein that I was drawing, which has an empty triangle space. This is actually really important. Each specific receptor, so the thing that's missing a triangle, can only bind to a few types and often only one specific type of ligand. So it can only bind that specific triangle pink ligand. Memory receptors allow our body and cells to transfer information and it can be very, very specific about it. This is important because when our body releases a hormone, it's kind of floating around in our entire bloodstream. How does our pancreas know that the hormone's intended for it and how would our heart cells not react to it? And this is why. The membrane receptors have a very specific preference for certain specific types of ligands. This is what we call our lock and key model. So if we imagine our ligand as the key and our receptor protein as a lock. Our receptor protein as a lock needs a very specific type of key in order to open it. So just like how our keychain we might have a key to our mailbox and a key to our front door, maybe a key to our desk, each of these keys does something different and opens a different lock. And that's kind of like how our cells work. Now I just want to make a note that this is a slightly outdated model. Our updated model is actually what we call induced fit. And these two concepts are very similar. But instead of saying that the ligands and the membrane receptors have a very, very specific shape, induced fit brings a little more flexibility. And it says the ligands and the membrane receptors can sometimes change confirmations. Kind of like how dough can be a little squishy so that they can fit each other. Overall there are still a ton of new membrane receptors that are being discovered. As far as we know, we can group membrane receptors into three large groups. The first group we call ligand gated ion channels. The second group we call G protein coupled receptors. And lastly our third group we call enzyme linked receptors. Now in summary, essentially we have really important membrane receptors in our cell membrane. And these are integral proteins that allow our cells to communicate with the outside environment. And the process in which these integral proteins work, these memory receptors work, is that we have a ligand which can be an ion or a molecule. It can bind to our integral protein causing a process that we call signal transduction. And signal transduction essentially means that our original signal, or our ligand, is propagated throughout the cell as different proteins are activated causing our intracellular response. Ligands and memory receptors have a very specific fit. Only specific ligands can bind with specific membrane receptors and we call this lock and key. A more updated name for it is induced fit, in which the ligands and memory receptors are a little more flexible, kind of like dough. Though actually slightly alter confirmations when they fit together. And all of these membrane receptors that we know so far can be grouped into three major groups. Ligand gated ion channels, G protein coupled receptors, and enzyme linked receptors.


Structure and mechanism

Many membrane receptors are transmembrane proteins. There are various kinds, including glycoproteins and lipoproteins.[1] Hundreds of different receptors are known and many more have yet to be studied.[2][3] Transmembrane receptors are typically classified based on their tertiary (three-dimensional) structure. If the three-dimensional structure is unknown, they can be classified based on membrane topology. In the simplest receptors, polypeptide chains cross the lipid bilayer once, while others, such as the G-protein coupled receptors, cross as many as seven times. Each cell membrane can have several kinds of membrane receptors, with varying surface distributions. A single receptor may also be differently distributed at different membrane positions, depending on the sort of membrane and cellular function. Receptors are often clustered on the membrane surface, rather than evenly distributed.[4][5]


Two models have been proposed to explain transmembrane receptors' mechanism of action.

  • Dimerization: The dimerization model suggests that prior to ligand binding, receptors exist in a monomeric form. When agonist binding occurs, the monomers combine to form an active dimer.
  • Rotation: Ligand binding to the extracellular part of the receptor induces a rotation (conformational change) of part of the receptor's transmembrane helices. The rotation alters which parts of the receptor are exposed on the intracellular side of the membrane, altering how the receptor can interact with other proteins within the cell.[6]


Transmembrane receptors in plasma membrane can usually be divided into three parts.

Extracellular domains

The extracellular domain just externally from the cell or organelle. If the polypeptide chain crosses the bilayer several times, the external domain comprises loops entwined through the membrane. By definition, a receptor's main function is to recognize and respond to a type of ligand. For example, a neurotransmitter, hormone, or atomic ions may each bind to the extracellular domain as a ligand coupled to receptor. Klotho is an enzyme which effects a receptor to recognize the ligand (FGF23).

Transmembrane domains

Two most abundant classes of transmembrane receptors are GPCR and single-pass transmembrane proteins.[7],[8] In some receptors, such as the nicotinic acetylcholine receptor, the transmembrane domain forms a protein pore through the membrane, or around the ion channel. Upon activation of an extracellular domain by binding of the appropriate ligand, the pore becomes accessible to ions, which then diffuse. In other receptors, the transmembrane domains undergo a conformational change upon binding, which effects intracellular conditions. In some receptors, such as members of the 7TM superfamily, the transmembrane domain includes a ligand binding pocket.

Intracellular domains

The intracellular (or cytoplasmic) domain of the receptor interacts with the interior of the cell or organelle, relaying the signal. There are two fundamental paths for this interaction:

  • The intracellular domain communicates via protein-protein interactions against effector proteins, which in turn pass a signal to the destination.
  • With enzyme-linked receptors, the intracellular domain has enzymatic activity. Often, this is tyrosine kinase activity. The enzymatic activity can also be due to an enzyme associated with the intracellular domain.

Signal transduction

External reactions and internal reactions for signal transduction (click to enlarge)
External reactions and internal reactions for signal transduction (click to enlarge)

Signal transduction processes through membrane receptors involve the external reactions, in which the ligand binds to a membrane receptor, and the internal reactions, in which intracellular response is triggered.[9][10]

Signal transduction through membrane receptors requires four parts:

  • Extracellular signaling molecule: an extracellular signaling molecule is produced by one cell and is at least capable of traveling to neighboring cells.
  • Receptor protein: cells must have cell surface receptor proteins which bind to the signaling molecule and communicate inward into the cell.
  • Intracellular signaling proteins: these pass the signal to the organelles of the cell. Binding of the signal molecule to the receptor protein will activate intracellular signaling proteins that initiate a signaling cascade.
  • Target proteins: the conformations or other properties of the target proteins are altered when a signaling pathway is active and changes the behavior of the cell.[10]
Three conformation states of acetylcholine receptor (click to enlarge)
Three conformation states of acetylcholine receptor (click to enlarge)

Membrane receptors are mainly divided by structure and function into 3 classes: The ion channel linked receptor; The enzyme-linked receptor; and The G protein-coupled receptor.

  • Ion channel linked receptors have ion channels for anions and cations, and constitute a large family of multipass transmembrane proteins. They participate in rapid signaling events usually found in electrically active cells such as neurons. They are also called ligand-gated ion channels. Opening and closing of ion channels is controlled by neurotransmitters.
  • Enzyme-linked receptors are either enzymes themselves, or directly activate associated enzymes. These are typically single-pass transmembrane receptors, with the enzymatic component of the receptor kept intracellular. The majority of enzyme-linked receptors are, or associate with, protein kinases.
  • G protein-coupled receptors are integral membrane proteins that possess seven transmembrane helices. These receptors activate a G protein upon agonist binding, and the G-protein mediates receptor effects on intracellular signaling pathways.

Ion channel-linked receptor

During the signal transduction event in a neuron, the neurotransmitter binds to the receptor and alters the conformation of the protein. This opens the ion channel, allowing extracellular ions into the cell. Ion permeability of the plasma membrane is altered, and this transforms the extracellular chemical signal into an intracellular electric signal which alters the cell excitability.[11]

Acetylcholine receptor is a receptor linked to a cation channel. The protein consists of 4 subunits: α, β, γ, and δ subunits. There are two α subunits, with one acetylcholine binding site each. This receptor can exist in three conformations. The closed and unoccupied state is the native protein conformation. As two molecules of acetylcholine both bind to the binding sites on α subunits, the conformation of the receptor is altered and the gate is opened, allowing for the entry of many ions and small molecules. However, this open and occupied state only lasts for a minor duration and then the gate is closed, becoming the closed and occupied state. The two molecules of acetylcholine will soon dissociate from the receptor, returning it to the native closed and unoccupied state.[12][13]

Enzyme-linked receptors

Sketch of an enzyme-linked receptor structure (structure of IGF-1R) (click to enlarge)
Sketch of an enzyme-linked receptor structure (structure of IGF-1R) (click to enlarge)

As of 2009, there are 6 known types of enzyme-linked receptors: Receptor tyrosine kinases; Tyrosine kinase associated receptors; Receptor-like tyrosine phosphatases; Receptor serine/threonine kinases; Receptor guanylyl cyclases and histidine kinase associated receptors. Receptor tyrosine kinases have the largest population and widest application. The majority of these molecules are receptors for growth factors such as epidermal growth factor (EGF), platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), hepatocyte growth factor (HGF), nerve growth factor (NGF) and hormones such as insulin. Most of these receptors will dimerize after binding with their ligands, in order to activate further signal transductions. For example, after the epidermal growth factor (EGF) receptor binds with its ligand EGF, the two receptors dimerize and then undergo phosphorylation of the tyrosine residues in the enzyme portion of each receptor molecule. This will activate the tyrosine kinase and catalyze further intracellular reactions.

G protein-coupled receptors

G protein-coupled receptors comprise a large protein family of transmembrane receptors. They are found only in eukaryotes.[14] The ligands which bind and activate these receptors include: photosensitive compounds, odors, pheromones, hormones, and neurotransmitters. These vary in size from small molecules to peptides and large proteins. G protein-coupled receptors are involved in many diseases, and thus are the targets of many modern medicinal drugs.[15]

There are two principal signal transduction pathways involving the G-protein coupled receptors: the cAMP signaling pathway and the phosphatidylinositol signaling pathway.[16] Both are mediated via G protein activation. The G-protein is a trimeric protein, with three subunits designated as α, β, and γ. In response to receptor activation, the α subunit releases bound guanosine diphosphate (GDP), which is displaced by guanosine triphosphate (GTP), thus activating the α subunit, which then dissociates from the β and γ subunits. The activated α subunit can further affect intracellular signaling proteins or target functional proteins directly.

Membrane receptor-related disease

If the membrane receptors are denatured or deficient, the signal transduction can be hindered and cause diseases. Some diseases are caused by disorders of membrane receptor function. This is due to deficiency or degradation of the receptor via changes in the genes that encode and regulate the receptor protein. The membrane receptor TM4SF5 influences the migration of hepatic cells and hepatoma.[17] Also, the cortical NMDA receptor influences membrane fluidity, and is altered in Alzheimer's disease.[18] When the cell is infected by a non-enveloped virus, the virus first binds to specific membrane receptors and then passes itself or a subviral component to the cytoplasmic side of the cellular membrane. In the case of poliovirus, it is known in vitro that interactions with receptors cause conformational rearrangements which release a virion protein called VP4.The N terminus of VP4 is myristylated and thus hydrophobic【myristic acid=CH3(CH2)12COOH】. It is proposed that the conformational changes induced by receptor binding result in the attachment of myristic acid on VP4 and the formation of a channel for RNA.

Structure-based drug design

Flow charts of two strategies of structure-based drug design
Flow charts of two strategies of structure-based drug design

Through methods such as X-ray crystallography and NMR spectroscopy, the information about 3D structures of target molecules has increased dramatically, and so has structural information about the ligands. This drives rapid development of structure-based drug design. Some of these new drugs target membrane receptors. Current approaches to structure-based drug design can be divided into two categories. The first category is about determining ligands for a given receptor. This is usually accomplished through database queries, biophysical simulations, and the construction of chemical libraries. In each case, a large number of potential ligand molecules are screened to find those fitting the binding pocket of the receptor. This approach is usually referred to as ligand-based drug design. The key advantage of searching a database is that it saves time and power to obtain new effective compounds. Another approach of structure-based drug design is about combinatorially mapping ligands, which is referred to as receptor-based drug design. In this case, ligand molecules are engineered within the constraints of a binding pocket by assembling small pieces in a stepwise manner. These pieces can be either atoms or molecules. The key advantage of such a method is that novel structures can be discovered.[19][20][21]

Other examples

See also


  1. ^ Cuatrecasas P. (1974). "MEMBRANE RECEPTORS". Annual Review of Biochemistry. 43 (0): 169–214. doi:10.1146/ PMID 4368906.
  2. ^ Dautzenberg FM, Hauger RL (February 2002). "The CRF peptide family and their receptors: yet more partners discovered". Trends Pharmacol. Sci. 23 (2): 71–7. doi:10.1016/S0165-6147(02)01946-6. PMID 11830263.
  3. ^ Rivière S, Challet L, Fluegge D, Spehr M, Rodriguez I (May 2009). "Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors". Nature. 459 (7246): 574–7. doi:10.1038/nature08029. PMID 19387439.
  4. ^ Rothberg K.G.; Ying Y.S.; Kamen B.A.; Anderson R.G. (1990). "Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate". The Journal of Cell Biology. 111 (6): 2931–2938. doi:10.1083/jcb.111.6.2931. PMC 2116385. PMID 2148564.
  5. ^ Jacobson C.; Côté P.D.; Rossi S.G.; Rotundo R.L.; Carbonetto S. (2001). "The Dystroglycan Complex Is Necessary for Stabilization of Acetylcholine Receptor Clusters at Neuromuscular Junctions and Formation of the Synaptic Basement Membrane". The Journal of Cell Biology. 152 (3): 435–450. doi:10.1083/jcb.152.3.435. PMC 2195998. PMID 11157973.
  6. ^ Maruyama, Ichiro N. (2015-09-01). "Activation of transmembrane cell-surface receptors via a common mechanism? The "rotation model"". BioEssays. 37 (9): 959–967. doi:10.1002/bies.201500041. ISSN 1521-1878. PMC 5054922. PMID 26241732.
  7. ^ Superfamilies of single-pass transmembrane receptors in Membranome database
  8. ^ Superfamilies of single-pass transmembrane protein ligands and regulators of receptors in Membranome database
  9. ^ Ullricha A.,Schlessingerb J.; Schlessinger, J (1990). "Signal transduction by receptors with tyrosine kinase activity". Cell. 61 (2): 203–212. doi:10.1016/0092-8674(90)90801-K. PMID 2158859.
  10. ^ a b Kenneth B. Storey (1990). Functional Metabolism. Wiley-IEEE. pp. 87–94. ISBN 0-471-41090-X.
  11. ^ Hille B. (2001). Ion channels of excitable membranes. Sunderland, Mass. ISBN 0-87893-321-2.
  12. ^ Miyazawa A.; Fujiyoshi Y.; Unwin N. (2003). "Structure and gating mechanism of the acetylcholine receptor pore". Nature. 423 (6943): 949–955. doi:10.1038/nature01748. PMID 12827192.
  13. ^ Akabas M.H.; Stauffer D.A.; Xu M.; Karlin A. (1992). "Acetylcholine receptor channel structure probed in cysteine-substitution mutants". Science. 258 (5080): 307–310. doi:10.1126/science.1384130. PMID 1384130.
  14. ^ King N, Hittinger CT, Carroll SB (2003). "Evolution of key cell signaling and adhesion protein families predates animal origins". Science. 301 (5631): 361–3. doi:10.1126/science.1083853. PMID 12869759.
  15. ^ Filmore, David (2004). "It's a GPCR world". Modern Drug Discovery. American Chemical Society. 2004 (November): 24–28.
  16. ^ Gilman A.G. (1987). "G Proteins: Transducers of Receptor-Generated Signals". Annual Review of Biochemistry. 56: 615–649. doi:10.1146/ PMID 3113327.
  17. ^ Müller-Pillascha F.; Wallrappa C.; Lachera U.; Friessb H.; Büchlerb M.; Adlera G.; Gress T. M. (1998). "Identification of a new tumour-associated antigen TM4SF5 and its expression in human cancer". Gene. 208 (1): 25–30. doi:10.1016/S0378-1119(97)00633-1. PMID 9479038.
  18. ^ Scheuer K.; Marasb A.; Gattazb W.F.; Cairnsc N.; Förstlb H.; Müller W.E. (1996). "Cortical NMDA Receptor Properties and Membrane Fluidity Are Altered in Alzheimer's Disease". Dementia. 7 (4): 210–214. doi:10.1159/000106881. PMID 8835885.
  19. ^ Wang R.; Gao Y.; Lai L. (2000). "LigBuilder: A Multi-Purpose Program for Structure-Based Drug Design". Journal of Molecular Modeling. 6 (7–8): 498–516. doi:10.1007/s0089400060498.
  20. ^ Schneider G.; Fechner U. (2005). "Computer-based de novo design of drug-like molecules". Nature Reviews Drug Discovery. 4 (8): 649–663. doi:10.1038/nrd1799. PMID 16056391.
  21. ^ Jorgensen W.L. (2004). "The Many Roles of Computation in Drug Discovery". Science. 303 (5665): 1813–1818. doi:10.1126/science.1096361. PMID 15031495.

External links

This page was last edited on 13 August 2018, at 19:29
Basis of this page is in Wikipedia. Text is available under the CC BY-SA 3.0 Unported License. Non-text media are available under their specified licenses. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc. WIKI 2 is an independent company and has no affiliation with Wikimedia Foundation.